Dr. Chun Xu

🔬 Nano Health Symposium 2025 Join us 10 Nov for a full-day event exploring how nanotech is transforming health! Hear from global experts, discover cutting-edge research & connect across disciplines. 📍 Sydney Nano sydney.edu.au/nano/news/even…

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2025 #NobelPrize in Chemistry to Susumu Kitagawa, Richard Robson and Omar M. Yaghi “for the development of metal–organic frameworks.”

Welcome The Inaugural Youth Editorial Board of the Journal Regenerative Medicine and Dentistry (RMD) sciltp.com/journals/rmd/a… We welcome high quality manuscript from the field of biomaterial, Regenerative Medicine, 3D printing and Dentistry

At the recent National Academy of Inventors (NAI) induction, one truth stood out clearly: So many of the honorees were immigrants. These are scientists and engineers who came to the United States with ideas, ambition, and a desire to contribute. They built labs, trained the next generation, and created technologies that are now part of the backbone of American innovation. This is not an accident. The U.S. has long been a magnet for global talent—not just because of its resources, but because it promised freedom to explore, freedom to collaborate, and a system that judged you by your work, not by where you were born. Yet now, we’re seeing a dangerous shift. Scientists are being quietly blacklisted, excluded from funding or opportunities—not based on any wrongdoing, but because they had students from certain countries. Or past affiliations that were completely legal, encouraged, and even celebrated just a few years ago. This echoes a darker time in U.S. history—McCarthyism, where guilt by association replaced fairness and due process. We cannot afford to go down that path again. Not morally. Not scientifically. Not economically. Innovation thrives in open environments. It withers under fear and suspicion. If we start canceling scientists for their global collaborations—rather than judging the actual merit of their work—we don’t just lose talent. We lose the future. Let’s be clear: 🧬 Immigrants fuel discovery. 🔬 Global science drives progress. 🗽 And freedom to think, teach, and explore is what made American innovation the envy of the world. We need to fight for that freedom now—before we lose it.

Another medical milestone! The first patient treated with a prime edited therapeutic shows positive clinical outcomes consistent with effective rescue of his chronic granulomatous disease (CGD), a debilitating and life-shortening primary immunodeficiency. At least 19 base editing and prime editing clinical trials have begun, with at least 7 trials reporting clinical outcomes (highlighted in green in the table below). They treat a wide range of diseases both in vivo and ex vivo. And while the U.S. support for science is now in crisis, that there are more base editing and prime editing clinical trials serving patients outside of the U.S. (13) than within the U.S. (9), despite the fact that these technologies were developed in our lab in the U.S. investors.primemedicine.com/news-releases/…

Please follow and connect me at LinkedIn as well.

Today marks the beginning of OpenRxiv, which replaces bioRxiv and medRxiv, the world's largest preprint platform for life and medical science @openrxiv

@Jess1E_zx Congratulations

My first PhD publication is out! For more details, see below 👇🏻

A real hero with big love. The spirit of Australia.

Former Australian of the Year heads into brain surgery after devastating scan smh.com.au/lifestyle/heal…

I am very proud to be part of the amazing team of researchers, scientists and clinicians who are all co-authors of the important research publication just released in Nature Medicine. The paper documents changes in my brain tumour & blood before and after I received neoadjuvant systemic combination immunotherapy treatment, which occurred in 2023. Everyone involved, including lead authors Georgina Long and Helen Rizos, used their expertise, knowledge and creative intellect to generate this important data just released. Whilst the paper deals with the data from just one patient (me), ultimately a clinical trial of a large group of patients needs to be conducted to determine whether or not neoadjuvant (pretreatment) combination immunotherapy is clinically effective in (a subgroup of) brain cancer patients. I hope such a trial begins in the not too distant future. Congratulations to everyone who has contributed to this research. What a fantastic achievement! But this is only the beginning & much more research is required to improve treatment and outcomes and ultimately save lives. @SydneyLHD @NthSydHealth @Sydney_Uni @COBLH #glioblastoma

The 2025 Young Tall Poppy science awards are now OPEN for nominations! Know an early career researcher who is making a significant impact in science AND also goes out of their way to communicate their science to the broader community? Nominate them today...

@Andrea_Loreto1 @SnowMedical Congratulations

Thrilled to be part of the Snow Vision Accelerator! Grateful for the generous investment from Tom Snow & @SnowMedical. Excited to work with an outstanding team of PIs, led by Prof. Jonathan Crowston, to tackle major challenges in glaucoma research & accelerate drug development.

We are delighted to announce our $50m transformative partnership, the Snow Vision Accelerator, with @Sydney_Uni. Led by renowned ophthalmologist Prof Jonathan Crowston, the Accelerator will fight glaucoma - the world’s leading cause of irreversible blindness. snowmedical.org.au

This is really going to make big changes

🚨 New Episode Alert! 🚨 Missed the last 100 episodes? No worries! 🎧 This week on the Joint Action Podcast, we bring you the ultimate guide to #osteoarthritis— from causes and treatments to exercise, diet, and groundbreaking research! Tune in now: open.spotify.com/episode/3hNinR…

📢📢 Abstract submissions & registration are now open! Join us in Sydney, Australia next year for the 14th International NanoMedicine Conference! #OzNanomed, oznanomed.org @MK_CCI @KrisKilian @peterwich @SophiaZiGu @TKumeria @JelenaRnjak @ronachandrawati @YingZhu827

We are hiring! An open position for a postdoctoral researcher with experience in biomaterials (carbon nanoparticles) and nanomedicine. Apply online: external-careers.jobs.unsw.edu.au/mob/en/job/530…

Thrilled to share our paper published at @natrevbioeng Personalized bioengineered implant scaffolds could revolutionize tissue repair with tailored solutions for individual patients. We explore clinical translation, key challenges and provide guidance @syd_health @cor3dentistry